Descriptor English: | Cyclophosphamide | ||||
Descriptor Spanish: |
Ciclofosfamida
| ||||
Descriptor Portuguese: | Ciclofosfamida | ||||
Descriptor French: | Cyclophosphamide | ||||
Entry term(s): |
(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate B 518 B-518 B518 Cyclophosphamide Anhydrous Cyclophosphamide Monohydrate Cyclophosphamide, (R)-Isomer Cyclophosphamide, (S)-Isomer Cyclophosphane Cytophosphan Cytophosphane Cytoxan Endoxan NSC 26271 NSC-26271 NSC26271 Neosar Procytox Sendoxan |
||||
Tree number(s): |
D02.455.526.728.650.730.243 D02.705.672.500.243 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003520 | ||||
Scope note: | Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Immunosuppressive Agents Mutagens Antirheumatic Agents Antineoplastic Agents, Alkylating Myeloablative Agonists |
||||
Registry Number: | 8N3DW7272P | ||||
DeCS ID: | 3540 | ||||
Unique ID: | D003520 | ||||
NLM Classification: | QV 269 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2018/05/21 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Cyclophosphamide
- Preferred
Sendoxan
- Narrower
B-518
- Narrower
Cyclophosphamide Anhydrous
- Narrower
Cyclophosphamide, (R)-Isomer
- Narrower
Cyclophosphamide, (S)-Isomer
- Narrower
Cytophosphane
- Narrower
Cyclophosphamide Monohydrate
- Narrower
Cytophosphan
- Narrower
Cytoxan
- Related but not broader or narrower
Endoxan
- Narrower
Neosar
- Narrower
NSC-26271
- Narrower
Procytox
- Narrower
(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate
- Narrower
Cyclophosphane
- Narrower
Concept UI |
M0005485 |
Scope note | Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. |
Preferred term | Cyclophosphamide |
Concept UI |
M0005490 |
Preferred term | Sendoxan |
Concept UI |
M0369305 |
Preferred term | B-518 |
Entry term(s) |
B 518 B518 |
Concept UI |
M0585642 |
Preferred term | Cyclophosphamide Anhydrous |
Concept UI |
M0331230 |
Preferred term | Cyclophosphamide, (R)-Isomer |
Concept UI |
M0331229 |
Preferred term | Cyclophosphamide, (S)-Isomer |
Concept UI |
M000638429 |
Preferred term | Cytophosphane |
Concept UI |
M000638430 |
Preferred term | Cyclophosphamide Monohydrate |
Concept UI |
M0582317 |
Preferred term | Cytophosphan |
Concept UI |
M0005486 |
Preferred term | Cytoxan |
Concept UI |
M0005487 |
Preferred term | Endoxan |
Concept UI |
M0005488 |
Preferred term | Neosar |
Concept UI |
M0369304 |
Preferred term | NSC-26271 |
Entry term(s) |
NSC 26271 NSC26271 |
Concept UI |
M0005489 |
Preferred term | Procytox |
Concept UI |
M000642260 |
Preferred term | (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate |
Concept UI |
M000638428 |
Preferred term | Cyclophosphane |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey